MPE will hold a webinar on ASH 2018 highlights in myeloma and AL amyloidosisAL amyloidosis, Conferences, MPE, MyelomaJanuary 16, 2019
Daratumumab increases progression-free survival in newly diagnosed myeloma patients ineligible for transplantMyelomaDecember 5, 2018
New data presented at ASH 2018 from an ongoing phase I clinical trial of CAR T cell therapy in relapsed/refractory myelomaConferences, MyelomaDecember 4, 2018
WECAN workgroup of patient advocates and industry experts releases guiding principles for reasonable legal agreements between patient advocates and pharmaceutical companiesMPENovember 28, 2018
Huge variations between countries in time for reimbursement decisions on new cancer drugsAccessOctober 20, 2018
Trust in non-conventional therapies by cancer patients not matched with proper awareness about their risksConferencesOctober 11, 2018
